221 related articles for article (PubMed ID: 33448228)
1. The incidence of unexpected gynaecological malignancies in hysterectomies carried out for benign indications.
Yildiz G; Mat E; Yildiz P; Gundogdu EC; Basol G; Kurt D; Kale A
J Obstet Gynaecol; 2021 Feb; 41(2):298-304. PubMed ID: 33448228
[TBL] [Abstract][Full Text] [Related]
2. Incidence of occult malignancies identified during hysterectomies performed for benign indications.
Topdagi Yilmaz EP; Cimilli Senocak GN; Topdagi YE; Aynaoglu Yildiz G; Kumtepe Y
J Gynecol Obstet Hum Reprod; 2020 Mar; 49(3):101620. PubMed ID: 31449888
[TBL] [Abstract][Full Text] [Related]
3. The incidence of unexpected uterine malignancies in hysterectomies carried out for benign indications.
Ding Y; Han Y; Zhang S; Shi X
J Cancer Res Clin Oncol; 2023 Jul; 149(8):4339-4345. PubMed ID: 36083311
[TBL] [Abstract][Full Text] [Related]
4. Unexpected gynecologic malignancy diagnosed after hysterectomy performed for benign indications.
Mahnert N; Morgan D; Campbell D; Johnston C; As-Sanie S
Obstet Gynecol; 2015 Feb; 125(2):397-405. PubMed ID: 25569001
[TBL] [Abstract][Full Text] [Related]
5. Incidence of sarcoma in patients undergoing hysterectomy for benign indications: a population-based study.
Multinu F; Casarin J; Tortorella L; Huang Y; Weaver A; Angioni S; Melis GB; Mariani A; Stewart EA; Laughlin-Tommaso SK
Am J Obstet Gynecol; 2019 Feb; 220(2):179.e1-179.e10. PubMed ID: 30447212
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of occult endometrial cancer in women undergoing hysterectomy for benign indications.
Parsons LHP; Pedersen R; Richardson DL; Kho KA
Eur J Obstet Gynecol Reprod Biol; 2018 Apr; 223():108-112. PubMed ID: 29518640
[TBL] [Abstract][Full Text] [Related]
7. Risk of Occult Uterine Sarcoma in Women Undergoing Hysterectomy for Benign Indications.
Kho KA; Lin K; Hechanova M; Richardson DL
Obstet Gynecol; 2016 Mar; 127(3):468-473. PubMed ID: 26855091
[TBL] [Abstract][Full Text] [Related]
8. Prevalence, characteristics, and risk factors of occult uterine cancer in presumed benign hysterectomy.
Desai VB; Wright JD; Gross CP; Lin H; Boscoe FP; Hutchison LM; Schwartz PE; Xu X
Am J Obstet Gynecol; 2019 Jul; 221(1):39.e1-39.e14. PubMed ID: 30853364
[TBL] [Abstract][Full Text] [Related]
9. Indications of hysterectomy.
Thompson JD; Birch HW
Clin Obstet Gynecol; 1981 Dec; 24(4):1245-58. PubMed ID: 7333047
[TBL] [Abstract][Full Text] [Related]
10. Patient, surgeon, and hospital disparities associated with benign hysterectomy approach and perioperative complications.
Mehta A; Xu T; Hutfless S; Makary MA; Sinno AK; Tanner EJ; Stone RL; Wang K; Fader AN
Am J Obstet Gynecol; 2017 May; 216(5):497.e1-497.e10. PubMed ID: 28034651
[TBL] [Abstract][Full Text] [Related]
11. Unexpected malignancy at the time of hysterectomy performed for a benign indication: A retrospective review.
Elliott CG; Murji A; Matelski J; Adekola AB; Chrzanowski J; Shirreff L
PLoS One; 2022; 17(4):e0266338. PubMed ID: 35363824
[TBL] [Abstract][Full Text] [Related]
12. Incidence and risk factors of unanticipated pathology in cases of hysterectomy for benign lesion a cross-section study in Al Shifa Medical Complex.
AbuSaqer SM; Shammala AIHA; Elejla S; Mahdi H; Laban RA; Hamada HA; Zimmo MW
Cancer Treat Res Commun; 2023; 35():100697. PubMed ID: 36989579
[TBL] [Abstract][Full Text] [Related]
13. Unexpected malignant uterine pathology: Incidence, characteristics and outcome in a large single-center series of hysterectomies for presumed benign uterine disease.
Wagner P; Kommoss FKF; Kommoss S; Hartkopf AD; Pasternak I; Oberlechner E; Greif K; Wallwiener M; Neis F; Abele H; Krämer B; Reisenauer C; Staebler A; Wallwiener D; Brucker SY; Taran FA
Gynecol Oncol; 2019 Apr; 153(1):49-54. PubMed ID: 30635214
[TBL] [Abstract][Full Text] [Related]
14. Incidence of Occult Uterine Malignancy Following Vaginal Hysterectomy With Morcellation.
Wasson M; Magtibay P; Magtibay P; Magrina J
J Minim Invasive Gynecol; 2017; 24(4):665-669. PubMed ID: 28254678
[TBL] [Abstract][Full Text] [Related]
15. Incidence, causes and surgical methods for hysterectomy in Finland, 1987-1989.
Luoto R; Kaprio J; Keskimäki I; Pohjanlahti JP; Rutanen EM
Int J Epidemiol; 1994 Apr; 23(2):348-58. PubMed ID: 8082962
[TBL] [Abstract][Full Text] [Related]
16. Unexpected malignancies after laparoscopic-assisted supracervical hysterectomies (LASH): an analysis of 1,584 LASH cases.
Theben JU; Schellong AR; Altgassen C; Kelling K; Schneider S; Große-Drieling D
Arch Gynecol Obstet; 2013 Mar; 287(3):455-62. PubMed ID: 23053310
[TBL] [Abstract][Full Text] [Related]
17. Incidence of Malignancy and Myoma Variants at Surgery for Presumed Benign Symptomatic Myomas.
Damasco MR; Chan PK; Slonim M; Ang WC; Healey MG
J Minim Invasive Gynecol; 2017; 24(4):659-664. PubMed ID: 28216458
[TBL] [Abstract][Full Text] [Related]
18. Occult Gynecologic Cancer in Women Undergoing Hysterectomy or Myomectomy for Benign Indications.
Desai VB; Wright JD; Schwartz PE; Jorgensen EM; Fan L; Litkouhi B; Lin H; Gross CP; Xu X
Obstet Gynecol; 2018 Apr; 131(4):642-651. PubMed ID: 29528920
[TBL] [Abstract][Full Text] [Related]
19. Power morcellation for women undergoing laparoscopic supracervical hysterectomy - safety of procedure and clinical experience from 426 cases.
Rechberger T; Miotła P; Futyma K; Ziętek A; Filipczak A; Rechberger E; Szumiło J; Adamiak-Godlewska A
Ginekol Pol; 2016; 87(8):546-51. PubMed ID: 27629127
[TBL] [Abstract][Full Text] [Related]
20. Risk of incidental genital tract malignancies at the time of myomectomy and hysterectomy for benign conditions.
Yadav G; Rao M; Goyal SB; Singh P; Kathuria P; Gothwal M
Obstet Gynecol Sci; 2021 Mar; 64(2):209-215. PubMed ID: 33321560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
